What Should an AI Agent Be Allowed to Do in the Revenue Cycle?
A practical autonomy framework for revenue cycle AI. Five levels, where the line should sit for coding, appeals and write-offs, and what governance actually requires.
Read more
Resources & Insights
Blog
Filter By:
Filter By Service
Filter By Category
Filter By Type
Patient Billing Statements: How Clearer Communication Improves Collections
Uncertainty about a bill contributes to nonpayment alongside affordability. See the five questions your patient billing statement should answer, and what to measure.
Read more
Generative, Predictive and Agentic AI in Revenue Cycle Management
Predictive, generative and agentic AI are not interchangeable. See what each does in revenue cycle management, where adoption really is and how to evaluate claims.
Read more
Urology Revenue Cycle Management in 2026: What the New IDR Rules and Site-of-Service Policies Mean
The 2026 federal IDR rule lowers the administrative fee to $15 and sets a 50-item batching limit from Nov. 1. Here is what urology practices should build for.
Read more
Rheumatology Prior Authorization: Protecting the Specialty Drug Claim From Order to Payment
How rheumatology practices protect high-dollar biologic and infusion claims from order to payment, from authorization scope to J-code units.
Read more
Protecting five-figure claims in immunology: biologics, J-codes and the documentation payers expect
Immunology biologics carry five-figure claims. See the revenue cycle steps, J-code accuracy and documentation payers expect that keep specialty-drug claims clean.
Read more
The Revenue Is Already Earned. Intelligent Automation Is How We Collect It Faster.
The practices that pull ahead aren’t billing more than anyone else. They’re collecting faster, cleaner and with far less manual...
Read more